Curcumin reduced the side effects of mitomycin C by inhibiting GRP58-mediated DNA cross-linking in MCF-7 breast cancer xenografts-Reference-Cited by-同舟云学术

Curcumin reduced the side effects of mitomycin C by inhibiting GRP58-mediated DNA cross-linking in MCF-7 breast cancer xenografts

Published:2009-11 Issue:11 Volume:100 Page:2040-2045
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Zhou Qian-Mei,Zhang Hui,Lu Yi-Yu,Wang Xiu-Feng,Su Shi-Bing

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2009.01297.x/fullpdf

Reference31 articles.

1. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival;Jemal;Cancer,2004

2. Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis;Linos;J Natl Cancer Inst,2008

3. Formation of DNA interstrand cross-links as a marker of Mitomycin C bioreductive activation and chemosensitivity;Volpato;Eur J Cancer,2005

4. Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation;Chalasani;JOP,2008

5. Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin C;Wu;Cancer Res,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remifentanil Promotes PDIA3 Expression by Activating p38MAPK to Inhibit Intestinal Ischemia/Reperfusion-Induced Oxidative and Endoplasmic Reticulum Stress;Frontiers in Cell and Developmental Biology;2022-01-26

2. ANTI-INVASION AND ANTI-METASTASIS EFFECTS OF DANDELION (TARAXACUM OFFICINALE) HYDROALCOHOLIC EXTRACT ON GLIOBLASTOMA MULTIFORME CELL LINE MODEL;WORLD CANCER RES J;2022

3. Natural products targeting cancer stem cells: Implications for cancer chemoprevention and therapeutics;Journal of Food Biochemistry;2021-05-24

4. Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer;EUR REV MED PHARMACO;2021

5. Insights into the role of ERp57 in cancer;Journal of Cancer;2021